Jean-Christophe Tellier joined UCB in 2011. He became UCB’s Chief Executive Officer on January 1, 2015 after having successfully led UCB’s BioBrands and Solutions division as Executive Vice President. He is a member of the Board of Directors of UCB, Chair of BCR (Biopharmaceutical CEOs Roundtable), President IFPMA (International Federation of Pharmaceutical Manufacturers & Associations), Member of the Board of the European Federation of Pharmaceutical Associations (EFPIA) and Vice-Chair of the Innovation Board Sponsored Committee (EFPIA).
He is also a member of the Board of PhRMA (Pharmaceutical Research and Manufacturers of America) and an independent health member of the Supervisory Board of Servier.
Jean-Christophe Tellier is an experienced global leader. He was trained as a Medical Doctor and specialized in rheumatology. He has built a distinguished 30+ year career in the biopharmaceutical industry, taking on different global leadership responsibilities in different parts of the world.
His patient-centric approach, his passion for science, combined with his strategic and operational skills, have allowed him to significantly contribute to UCB’s success in recent years. Jean-Christophe believes that the best way to have a positive impact on society and continue to thrive is to deliver on our commitments to patients and our stakeholders. To this end he has led the integration of our sustainability approach into our strategy to help UCB improve its societal impact while ensuring that we continue to perform well as a company.
He has also been instrumental in humanizing UCB’s approach towards patients, developing the company’s Patient Value Strategy. For Jean-Christophe “engaging the patient in our visionis the best way for our company to be successful in the long term. Having a holistic view of a patient, of his/her life in his/her environment is essential to ensure effective treatment”. Jean-Christophe also believes that “all healthcare players - physicians, payors, carers, industry and academia - should cooperate even more effectively and become stronger partners sharing a same goal: improving patient care”.
As a leader, Jean-Christophe has always had a passion for developing people, which he sees as “a key force to drive company success”. His ambition is to continue to further engage UCB teams behind the company’s vision and fully leverage UCB’s strong culture and talents.
Prior to UCB, Jean-Christophe was President and General Manager of Ipsen’s North American operations, Executive Vice President and Chief Commercial Officer of Macrogenics: Maryland-based public biotechnology company, CEO of Novartis Pharma France and CEO of Novartis Pharma Belgium. At Novartis he held several local and global marketing and sales positions and was a.o. Head of Novartis’ Global Business Franchise in Arthritis, Bone and Muscle Disease.
He holds a Doctor of Medicine (M.D.) from the University of Reims Champagne-Ardenne (France) and was a post-graduate in rheumatology at the Université de Paris. He has also attended executive business programs at both Harvard and INSEAD.